Epilepsy is a group of syndromes characterized by recurringseizures. Epileptic syndromes are classified by specific patterns of clinical features, including age of onset, family history, and seizure type (Schachter, 2001). Types of epilepsies are differentiated by how the seizure activity manifests (see Chart 61-3), the most common syndromes being those with generalized seizures and those with partial-onset seizures. Epilepsy can be primary (idio-pathic) or secondary, when the cause is known and the epilepsy is a symptom of another underlying condition such as a brain tumor (Schachter, 2001).
An estimated 2 to 4 million people in the United States have epilepsy (1 in 100 adults is affected), and onset occurs before the age of 20 years in greater than 75% of patients (Schacter, 2001). The improved treatment of cerebrovascular disorders, head in-juries, brain tumors, meningitis, and encephalitis has increased the number of patients at risk for seizures following recovery from these conditions (Berges et al., 2000). Also, advances in EEG have aided in the diagnosis of epilepsy. The general public has been educated about epilepsy, which has reduced the stigma as-sociated with it; as a result, more people are willing to acknowl-edge the diagnosis.
Although there is evidence that susceptibility to some types of epilepsy may be inherited, the cause of seizures in many people is unknown. Epilepsy can follow birth trauma, asphyxia neonatorum, head injuries, some infectious diseases (bacterial, viral, parasitic), toxicity (carbon monoxide and lead poisoning), circu-latory problems, fever, metabolic and nutritional disorders, and drug or alcohol intoxication (Schachter, 2001). It is also associ-ated with brain tumors, abscesses, and congenital malformations. In most cases of epilepsy, the cause is unknown (idiopathic).
Messages from the body are carried by the neurons (nerve cells) of the brain by means of discharges of electrochemical energy that sweep along them. These impulses occur in bursts whenever a nerve cell has a task to perform. Sometimes, these cells or groups of cells continue firing after a task is finished. During the period of unwanted discharges, parts of the body controlled by the er-rant cells may perform erratically. Resultant dysfunction ranges from mild to incapacitating and often causes unconsciousness (Greenberg, 2001; Hickey, 2003). When these uncontrolled, ab-normal discharges occur repeatedly, a person is said to have an epileptic syndrome (Schachter, 2001).
Epilepsy is not associated with intellectual level. People with epilepsy without other brain or nervous system disabilities fall within the same intelligence ranges as the overall population. Epilepsy is not synonymous with mental retardation or illness. Many who are developmentally disabled because of serious neu-rologic damage, however, have epilepsy as well.
Depending on the location of the discharging neurons, seizures may range from a simple staring episode to prolonged convulsive movements with loss of consciousness. Seizures have been classi-fied according to the area of the brain involved and have been identified as partial, generalized, and unclassified (Greenberg, 2001; Hickey, 2003). Partial seizures are focal in origin and af-fect only part of the brain. Generalized seizures are nonspecific in origin and affect the entire brain simultaneously. Unclassified seizures are so termed because of incomplete data.
The initial pattern of the seizures indicates the region of the brain in which the seizure originates (see Chart 61-2). In simple partial seizures, only a finger or hand may shake, or the mouth may jerk uncontrollably. The person may talk unintelligibly, may be dizzy, and may experience unusual or unpleasant sights, sounds, odors, or tastes, but without loss of consciousness (Greenberg, 2001; Hickey, 2003).
In complex partial seizures, the person either remains mo-tionless or moves automatically but inappropriately for time and place, or may experience excessive emotions of fear, anger, ela-tion, or irritability. Whatever the manifestations, the person does not remember the episode when it is over.
Generalized seizures, previously referred to as grand mal seizures, involve both hemispheres of the brain, causing both sides of the body to react (Greenberg, 2001; Hickey, 2003). There may be intense rigidity of the entire body followed by alternating muscle relaxation and contraction (generalized tonic–clonic contrac-tion). The simultaneous contractions of the diaphragm and chest muscles may produce a characteristic epileptic cry. The tongue is often chewed, and the patient is incontinent of urine and stool. After 1 or 2 minutes, the convulsive movements begin to subside; the patient relaxes and lies in deep coma, breathing noisily. The respirations at this point are chiefly abdominal. In the postictal state (after the seizure), the patient is often confused and hard to arouse and may sleep for hours. Many patients complain of headache, sore muscles, fatigue, and depression (Buelow, 2001).
The diagnostic assessment is aimed at determining the type of seizures, their frequency and severity, and the factors that pre-cipitate them (Schachter, 2001). A developmental history istaken, including events of pregnancy and childbirth, to seek evi-dence of preexisting injury. The patient is also questioned about illnesses or head injuries that may have affected the brain. In ad-dition to physical and neurologic evaluations, diagnostic exami-nations include biochemical, hematologic, and serologic studies. MRI is used to detect lesions in the brain, focal abnormalities, cerebrovascular abnormalities, and cerebral degenerative changes (Schachter, 2001).
The electroencephalogram (EEG) furnishes diagnostic evi-dence in a substantial proportion of patients with epilepsy and aids in classifying the type of seizure (Schachter, 2001). Abnor-malities in the EEG usually continue between seizures or, if not apparent, may be elicited by hyperventilation or during sleep. Microelectrodes can be inserted deep in the brain to probe the action of single brain cells. Some people with seizures have nor-mal EEGs, whereas others who have never had seizures have ab-normal EEGs. Telemetry and computerized equipment are used to monitor electrical brain activity while patients pursue their normal activities and to store the readings on computer tapes for analysis. Video recording of seizures taken simultaneously with EEG telemetry is useful in determining the type of seizure as well as its duration and magnitude. This type of intensive monitoring is changing the treatment of severe epilepsy.
Single photon emission computed tomography (SPECT) is an additional tool sometimes used in the diagnostic workup. It is useful for identifying the epileptogenic zone so that the area in the brain giving rise to seizures can be removed surgically (Huntington, 1999).
More than 1 million American women have epilepsy, and they face particular needs associated with the syndrome (Schachter, Krishnamurthy & Cantrell, 2000). Women with epilepsy often note an increase in seizure frequency during menses; this has been linked to the increase in sex hormones that alter the excitability of neurons in the cerebral cortex. Women of childbearing age re-quire special care and guidance before, during, and after preg-nancy. Many women note a change in the pattern of seizure activity during pregnancy. Fetal malformation has been linked to the use of multiple antiseizure medications (Karch, 2002). The effectiveness of contraceptives is decreased by antiseizure med-ications. Therefore, patients should be encouraged to discuss family planning with their primary health care provider and to obtain preconception counseling if they are considering child-bearing (Liporace, 1997).
Because of bone loss associated with the long-term use of anti-seizure medications, patients receiving antiseizure agents should be assessed for low bone mass and osteoporosis. They should be instructed about other strategies to reduce their risks for osteoporosis.
Elderly people have a high incidence of new-onset epilepsy (Schachter, 2001). Increased incidence is associated with stroke, head injury, dementia, infection, alcoholism, and aging. Treat-ment depends on the underlying cause. Because many elderly people have chronic health problems, they may be taking other medications that can interact with medications prescribed for seizure control. In addition, the absorption, distribution, metab-olism, and excretion of medications are altered in the elderly as a result of age-related changes in renal and liver function. Therefore, the elderly must be monitored closely for adverse and toxic effects of antiseizure medications and for osteoporosis. The cost of antiseizure medications can lead to poor adherence to the pre-scribed regimen in elderly patients on fixed incomes.
Society-wide efforts are the key to the prevention of epilepsy. The risk for congenital fetal anomaly is two to three times higher in mothers with epilepsy. The effects of maternal seizures, antiseizure medications, and genetic predisposition are all mechanisms that contribute to possible malformation. Because the unborn infants of mothers who take certain antiseizure medications for epilepsy are at risk, these women need careful monitoring, including blood studies to detect the level of antiseizure medications taken through-out pregnancy (Karch, 2002). High-risk mothers (teenagers, women with histories of difficult deliveries, drug use, patients with diabetes or hypertension) should be identified and moni-tored closely during pregnancy because damage to the fetus during pregnancy and delivery may increase the risk for epilepsy. All of these issues need further study (Schachter, Krishnamurthy & Cantrell, 2000).
Head injury is one of the main causes of epilepsy that can be prevented.
The management of epilepsy is individualized to meet the needs of each patient and not just to manage and prevent seizures. Man-agement differs from patient to patient because some forms of epilepsy arise from brain damage and others are due to altered brain chemistry.
Many medications are available to control seizures, although the mechanisms of their actions are still unknown (Karch, 2002). The objective is to achieve seizure control with minimal side effects. Medication therapy controls rather than cures seizures. Medications are selected on the basis of the type of seizure being treated and the effectiveness and safety of the medications (Shafer, 1999a, 1999b; Winkelman, 1999). If properly prescribed and taken, medications control seizures in 50% to 60% of patients with recurring seizures and provide partial control in another 15% to 35%. The condition is not improved by any available medication in 20% and 35% of patients with generalized and partial epilepsy, respectively (Devinsky, 1999).
Treatment is usually started with a single medication. The starting dose and the rate at which the dosage is increased depend on the occurrence of side effects. The medication levels in the blood are monitored because the rate of drug absorption varies among patients. Changing to another medication may be neces-sary if seizure control is not achieved or if toxicity makes it impossible to increase the dosage. The medication may need to be adjusted because of concurrent illness, weight changes, or in-creases in stress. Sudden withdrawal of these medications can cause seizures to occur with greater frequency or can precipitate the development of status epilepticus (Greenberg, 2001).
Side effects of antiseizure agents may be divided into three groups: (1) idiosyncratic or allergic disorders, which present pri-marily as skin reactions; (2) acute toxicity, which may occur whenthe medication is initially prescribed; or (3) chronic toxicity, which occurs late in the course of therapy.
The manifestations of drug toxicity are variable, and any organ system may be involved. Gingival hyperplasia (swollen and tender gums) can be associated with long-term use of phenyt-oin (Dilantin), for example (Karch, 2002). Periodic physical and dental examinations and laboratory tests are performed for pa-tients receiving medications known to have hematopoietic, gen-itourinary, or hepatic effects. Table 61-4 lists the medications in current use.
Surgery is indicated for patients whose epilepsy results from in-tracranial tumors, abscess, cysts, or vascular anomalies. Some pa-tients have intractable seizure disorders that do not respond to medication. There may be a focal atrophic process secondary to trauma, inflammation, stroke, or anoxia. If the seizures originate in a reasonably well-circumscribed area of the brain that can be excised without producing significant neurologic deficits, the re-moval of the area generating the seizures may produce long-term control and improvement (Wiebe, Blume, Girvin et al., 2001).
This type of neurosurgery has been aided by several advances, including microsurgical techniques, depth EEGs, improved illu-mination and hemostasis, and the introduction of neurolept-analgesic agents (droperidol and fentanyl). These techniques, combined with use of local anesthetic agents, enable the neuro-surgeon to perform surgery on an alert and cooperative patient. Using special testing devices, electrocortical mapping, and the pa-tient’s response to stimulation, the boundaries of the epilepto-genic focus are determined (Huntington, 1999). Any abnormal epileptogenic focus (ie, abnormal area of the brain) is then re-moved (Wiebe et al., 2001).
As an adjunct to medication and surgery in adolescents and adults with partial seizures, a generator may be implanted under the clavicle. The device is connected to the vagus nerve in the cervical area, where it delivers electrical signals to the brain to control and reduce seizure activity (Kennedy & Schallert, 2001). An external programming system is used by the physician to change stimulator settings. Patients can turn the stimulator on and off with a magnet.